e-learning
resources
Virtual 2020
Pre-Congress Content
Natural history and management of interstitial lung diseases of known cause
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
King’s Brief Interstitial Lung Disease (K-BILD) questionnaire: content relevance in progressive fibrosing ILD (PF-ILD)
S. Birring (London, United Kingdom), D. Bushnell (Bethesda, MD, United States of America), K. Cutts (Bethesda, MD, United States of America), M. Baldwin (Ingelheim am Rhein, Germany), K. Rohr (Ingelheim am Rhein, Germany), N. Male (Ingelheim am Rhein, Germany)
Source:
Virtual Congress 2020 – Natural history and management of interstitial lung diseases of known cause
Session:
Natural history and management of interstitial lung diseases of known cause
Session type:
E-poster session
Number:
1813
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Birring (London, United Kingdom), D. Bushnell (Bethesda, MD, United States of America), K. Cutts (Bethesda, MD, United States of America), M. Baldwin (Ingelheim am Rhein, Germany), K. Rohr (Ingelheim am Rhein, Germany), N. Male (Ingelheim am Rhein, Germany). King’s Brief Interstitial Lung Disease (K-BILD) questionnaire: content relevance in progressive fibrosing ILD (PF-ILD). 1813
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
HISTOLOGICAL FINDINGS IN TRANSBRONCHIAL CRYOBIOPSIES OBTAINED FROM PATIENTS AFTER COVID-19
Does “UIPAF” really exist?
Diagnosis and management of chronic fibrotic hypersensitivity pneumonitis
Related content which might interest you:
Translation and validation of the King's brief interstitial lung disease (K-BILD) questionnaire in French, Italian and Dutch
Source: International Congress 2014 – ILDs 2
Year: 2014
King's Brief Interstitial Lung Disease questionnaire: responsiveness and minimum clinically important difference
Source: Eur Respir J, 54 (3) 1900281; 10.1183/13993003.00281-2019
Year: 2019
Response of the King’s brief interstitial lung disease (KBILD) questionnaire to pulmonary rehabilitation (PR)
Source: International Congress 2015 – Latest insights in pulmonary rehabilitation and functional capacity
Year: 2015
The King’s brief interstitial lung disease (K-BILD) questionnaire; an updated minimal important difference
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016
Validation of the King’s Brief Interstitial Lung Disease questionnaire in Danish
Source: International Congress 2018 – Consequences of idiopathic interstitial pneumonias
Year: 2018
Value of community based Pulmonary Rehabilitation (PR) for patients with Interstitial Lung Disease (ILD): A retrospective review
Source: International Congress 2019 – Pulmonary rehabilitation for non-obstructive lung diseases
Year: 2019
Translation and preliminary validation of the KBILD QOL questionnaire to Spanish
Source: International Congress 2014 – ILDs 6
Year: 2014
Comparison of changes of the King’s brief interstitial lung disease questionnaire (K-BILD) with other health status measures
Source: International Congress 2016 – IPF: from pathogenesis to treatment I
Year: 2016
Depression and anxiety in pulmonary fibrosis: A pilot study
Source: International Congress 2015 – IPF: clinical aspects
Year: 2015
A comparison of two scoring methods for the King’s sarcoidosis questionnaire
Source: International Congress 2015 – Sarcoidosis: clinical
Year: 2015
The validation of the Severe Asthma Questionnaire (SAQ).
Source: International Congress 2018 – Asthma management
Year: 2018
Psychometric validation of the Visual Simplified Respiratory Questionnaire (VSRQ) in France for chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2005; 26: Suppl. 49, 512s
Year: 2005
Inmunosuppresor therapy effectivness in Interstitial Lung Disease (ILD) associated Connective Tisuue Disease(CTD).
Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment
Year: 2017
Evaluation of Dyspnea Questionnaires in Patients with Idiopathic Pulmonary Fibrosis (IPF).
Source: International Congress 2018 – Consequences of idiopathic interstitial pneumonias
Year: 2018
Physical activity and symptom burden in COPD: The Canadian Cohort Obstructive Lung Disease (CanCOLD) study
Source: Virtual Congress 2021 – Lung disease burden and management
Year: 2021
Hypersentivity pneumonitis in an Interstitial Lung Disease Unit, 5 years’ experience
Source: Virtual Congress 2020 – Natural history and management of interstitial lung diseases of known cause
Year: 2020
Health Related Quality of Life (HRQL) in sarcoidosis – Sarcoidosis Health Questionnaire (SHQ) and correlation with clinical course of sarcoidosis – follow up study
Source: Eur Respir J 2006; 28: Suppl. 50, 95s
Year: 2006
The Hospital Anxiety and Depression Scale (HADS) in Bronchiectasis: Response to pulmonary rehabilitation (PR) and Minimum Clinically Important Difference (MCID)
Source: International Congress 2019 – Hot topics in pulmonary rehabilitation
Year: 2019
Unclassifiable Interstitial Lung Disease (ILD). Why?
Source: Virtual Congress 2021 – Interstitial lung disease around the world
Year: 2021
Correlations between Lung Clearance Index (LCI) measurements and spirometry in Chronic Obstructive Pulmonary Disease (COPD).
Source: International Congress 2019 – Role of the physiotherapist for patients with lung disease
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept